Last reviewed · How we verify
Physician standard-of-care
Physician standard-of-care is a Small molecule drug developed by Merck Sharp & Dohme LLC. It is currently in Phase 2 development.
At a glance
| Generic name | Physician standard-of-care |
|---|---|
| Sponsor | Merck Sharp & Dohme LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in Infertility
- Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer (NA)
- Spot Analysis of Natriuresis to Guide up- or Down-titration of Diuretic Therapy in Ambulatory Patients With Chronic Heart Failure (NA)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MyeloMATCH Treatment Trial) (PHASE2)
- Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer
- Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer (PHASE3)
- HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer (EARLY_PHASE1)
- Canadian Critical Care Comparative Effectiveness Platform (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Physician standard-of-care CI brief — competitive landscape report
- Physician standard-of-care updates RSS · CI watch RSS
- Merck Sharp & Dohme LLC portfolio CI
Frequently asked questions about Physician standard-of-care
What is Physician standard-of-care?
Physician standard-of-care is a Small molecule drug developed by Merck Sharp & Dohme LLC.
Who makes Physician standard-of-care?
Physician standard-of-care is developed by Merck Sharp & Dohme LLC (see full Merck Sharp & Dohme LLC pipeline at /company/merck).
What development phase is Physician standard-of-care in?
Physician standard-of-care is in Phase 2.
Related
- Manufacturer: Merck Sharp & Dohme LLC — full pipeline
- Compare: Physician standard-of-care vs similar drugs
- Pricing: Physician standard-of-care cost, discount & access